Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erlotinib, Cisplatin, and Radiation in Resected Head and Neck Cancer
NCT00442455Phase 3Completed
- Sponsor
- GICOR
- Start
- Jan 2006
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of erlotinib in squamous cell carcinoma of the head and neck (HNSCC), sponsored by GICOR. Started Jan 2006; status: completed.
02
Drugs
erlotinib
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00442455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00442455.